归创通桥医疗科技股份有限公司(股票代码：02190)于2026年3月23日公告，该公司在香港联交所场内回购15万股H股股份，占当日已发行股本约0.0445%。每股回购价介乎港币22.24港元至23.16港元，总涉资约340.51万港元。
本次回购完成后，公司已发行股本为329,253,613股，库藏股数量增至7,097,131股。据公告显示，公司回购授权于2025年5月30日获通过，可回购的股份总数为31,958,111股，目前已累计回购4,277,500股。
公司同时确认，此次回购行为已获得董事会正式授权，并遵守所有适用的上市规则及相关法规。公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.